Solid-form risk intelligence in two weeks
Fast CSP is a low-friction entry point into computational solid-form analysis. Submit a molecular structure and receive a full risk assessment — no experimental work, no lengthy procurement, no synthesis required.
A rapid, structured entry into solid-form analysis
Fast CSP is a fixed-scope, fixed-timeline engagement that delivers the core intelligence of CHEMINA™ without the complexity of a full programme. It is designed for teams at any stage of development who need to understand their solid-form landscape quickly.
Unlike experimental screening, Fast CSP requires no lab access, no solvent libraries, and no prior polymorph work. The entire process runs computationally — making it accessible from day one of a development programme.
Two-week turnaround
From molecular structure submission to full risk report — delivered in as little as fourteen days.
Fixed scope and deliverables
A defined output every time — no ambiguity about what you'll receive or when.
No experimental prerequisite
A molecular structure is all that's needed. No synthesis, no prior screening, no lab work required.
Minimal input. Maximum intelligence.
Fast CSP is designed to remove the barriers that delay solid-form analysis. The input requirements are intentionally minimal.
Molecular structure
SMILES string, InChI, or structure file. No synthesis or crystallisation required.
Dev context
Programme stage, known experimental data, or specific risk areas to prioritise.
IP context
Known patents or filing timelines that should inform the solid-form analysis.
A complete risk assessment, ready to act on
Every Fast CSP engagement delivers the same structured output — designed to inform decisions, not generate more questions.
Full solid-form landscape
A ranked map of all predicted polymorphs, solvates, and co-crystals for your molecule — computationally exhaustive.
Polymorph risk flags
Each form assessed for stability, solubility impact, and regulatory relevance — ranked by development priority.
Screening guidance
Prioritised recommendations for any experimental follow-up, focusing resource where it matters most.
IP overview
Initial view of known solid-form patents to inform freedom-to-operate and exclusivity strategy.
Expert debrief
Structured review session with the Biosimulytics team to walk through findings, answer questions, and align on next steps.
Early insight that changes how programmes are run
Fast CSP fits into any development timeline — and delivers the most value when used earliest.
Pre-candidate selection
Identify the optimal solid form before committing to a development candidate — avoid downstream surprises entirely.
IND preparation
Generate the solid-form characterisation data required by ICH Q6A ahead of your filing timeline.
Licensing and partnering
Strengthen your data package with a comprehensive solid-form risk assessment before entering due diligence.
IP protection
Map the full solid-form space to identify patentable forms and assess exposure to third-party patents.
Formulation planning
Understand which solid forms are accessible and stable before committing to a formulation strategy.
Late-stage de-risking
Resolve outstanding polymorph questions quickly and de-risk your programme before Phase II or III investment scales.
Ready to asess your molecule's solid-form landscape?
Whether you want a rapid Fast CSP or a conversation about your programme, we are happy to talk. No commitment required.
